- Home
- BRKR vs CAI Comparison
BRKR vs CAI Comparison
Compare BRKR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRKR | CAI |
|---|---|---|
| Founded | 1960 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.4B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRKR | CAI |
|---|---|---|
| Price | $43.97 | $16.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $48.54 | $30.91 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,895,600,000.00 | N/A |
| Revenue This Year | $6.30 | $25.24 |
| Revenue Next Year | $3.81 | $22.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.53 | $16.28 |
| 52 Week High | $56.22 | $42.50 |
Technical Indicators
Market Signals| Indicator | BRKR | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 68.47 | 34.94 |
| Support Level | $33.09 | N/A |
| Resistance Level | $49.44 | $19.66 |
| Average True Range (ATR) | 2.01 | 1.07 |
| MACD | 0.72 | -0.24 |
| Stochastic Oscillator | 95.58 | 2.60 |
Price Performance
Historical ComparisonAbout BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.